Table 4. Univariate analysis by log-rank test of the impact of metabolism-related protein expression in estrogen receptor-negative breast cancer on disease-free survival and overall survival times.

		Disease-free survival (months)		Overall survival (months)
Parameters		95% CI	P-value	95% CI	P-value
Beclin-1 (T)			0.295		0.917
	Negative	114 (106–123)		124 (117–131)
	Positive	97 (92–101)		119 (113–125)
LC3A (T)			0.596		0.314
	Negative	117 (110–125)		123 (116–129)
	Positive	111 (100–122)		129 (120–137)
LC3A (S)			0.537		0.796
	Negative	117 (109–124)		125 (119–130)
	Positive	75 (70–80)		76 (72–80)
LC3B (T)			0.325		0.432
	Negative	114 (105–123)		121 (114–129)
	Positive	116 (108–124)		121 (115–127)
p62 (T)			0.907		0.289
	Negative	112 (99–125)		117 (106–128)
	Positive	117 (111–124)		126 (120–131)
p62 (S)			0.850		0.616
	Negative	118 (111–125)		126 (121–132)
	Positive	91 (83–99)		111 (100–122)
BNIP3 (T)			0.750		n/a
	Negative	117 (110–124)		n/a
	Positive	90 (83–97)		n/a
BNIP3 (S)			0.570		n/a
	Negative	117 (110–124)		n/a
	Positive	93 (84–102)		n/a